NDUFA13 and inflammatory bowel disease: In a study of patients with inflammatory bowel disease (IBD) viz., Crohn disease (CD) and Ulcerative Colitis (UC), Barnich et al. (2005) showed significantly lower abundance of GRIM-19 in the involved areas compared to the non-involved areas of the intestinal mucosa.